Literature DB >> 9052679

Measurement of tumor oxygenation: a comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensor.

D R Collingridge1, W K Young, B Vojnovic, P Wardman, E M Lynch, S A Hill, D J Chaplin.   

Abstract

A novel oxygen sensor which does not rely on electrochemical reduction has been used to measure the oxygenation of the murine sarcoma F in a comparative study with an existing polarographic electrode that is available commercially. The prototype luminescence sensor yielded an oxygen distribution comparable with readings made using a pO2 histograph. The percentage of regions detected that had a pO2 less than 5 mm Hg was 79 and 75 using the Eppendorf pO2 histograph and the luminescence fiber optic sensor, respectively. These values were compatible with a measured radiobiologically hypoxic fraction of 67% in this tumor. The polarographic method detected more regions with a pO2 of 2.5 mm Hg or less (69%) compared with the optical sensor (50%) (P < 0.05). This could reflect differences in the oxygen use of the sensing devices. This initial assessment indicates the potential of a fiber-optic-based oxygen-monitoring system. Such a system should have several advantages including monitoring temporal oxygen changes in a given microregion and use with NMR procedures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052679

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  13 in total

1.  Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements.

Authors:  Olivia J Kelada; Sara Rockwell; Ming-Qiang Zheng; Yiyun Huang; Yanfeng Liu; Carmen J Booth; Roy H Decker; Uwe Oelfke; Richard E Carson; David J Carlson
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

2.  Understanding the microcirculation in sepsis: still a long way to go...

Authors:  Yasser Sakr
Journal:  Intensive Care Med       Date:  2011-04-30       Impact factor: 17.440

3.  A robotic system for 18F-FMISO PET-guided intratumoral pO2 measurements.

Authors:  Jenghwa Chang; Bixiu Wen; Peter Kazanzides; Pat Zanzonico; Ronald D Finn; Gabor Fichtinger; C Clifton Ling
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

4.  Influence of 100% and 40% oxygen on penumbral blood flow, oxygen level, and T2*-weighted MRI in a rat stroke model.

Authors:  Tracey A Baskerville; Graeme A Deuchar; Christopher McCabe; Craig A Robertson; William M Holmes; Celestine Santosh; I Mhairi Macrae
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-11       Impact factor: 6.200

5.  Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivo.

Authors:  Vassiliki Kostourou; Helen Troy; Joanne F Murray; Elizabeth R Cullis; Guy St J Whitley; John R Griffiths; Simon P Robinson
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

6.  Direct Quantification and Comparison of Intratumoral Hypoxia following Transcatheter Arterial Embolization of VX2 Liver Tumors with Different Diameter Microspheres.

Authors:  Elliot B Levy; Carmen Gacchina Johnson; Genevieve Jacobs; David L Woods; Karun V Sharma; John D Bacher; Andrew L Lewis; Matthew R Dreher; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2015-07-29       Impact factor: 3.464

7.  Proportion of infiltrating IgG-binding immune cells predict for tumour hypoxia.

Authors:  D R Collingridge; S A Hill; D J Chaplin
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

Review 8.  Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models.

Authors:  Jinsong Hu; Els Van Valckenborgh; Eline Menu; Elke De Bruyne; Karin Vanderkerken
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758

9.  Temporal heterogeneity in oxygen tension in human melanoma xenografts.

Authors:  K G Brurberg; B A Graff; E K Rofstad
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

10.  In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography.

Authors:  H Barthel; H Wilson; D R Collingridge; G Brown; S Osman; S K Luthra; F Brady; P Workman; P M Price; E O Aboagye
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.